Multifunctional Nanoparticulate Polyelectrolyte Complexes

被引:0
作者
Sean M. Hartig
Rachel R. Greene
Mikhail M. Dikov
Ales Prokop
Jeffrey M. Davidson
机构
[1] University of Texas MD Anderson Cancer Center,Divison of Pediatrics Research
[2] Vanderbilt University,Department of Chemical Engineering
[3] Vanderbilt University School of Medicine,Department of Medicine, Hematology/Oncology Division
[4] Vanderbilt University School of Medicine,Department of Pathology
[5] VA Tennessee Valley Healthcare System,Research Service
来源
Pharmaceutical Research | 2007年 / 24卷
关键词
biomaterials; controlled release/delivery; endothelial targeting; models; polyelectrolyte complexes;
D O I
暂无
中图分类号
学科分类号
摘要
Water-soluble, biodegradable, polymeric, polyelectrolyte complex dispersions (PECs) have evolved because of the limitations, in terms of toxicity, of the currently available systems. These aqueous nanoparticulate architectures offer a significant advantage for products that may be used as drug delivery systems in humans. PECs are created by mixing oppositely charged polyions. Their hydrodynamic diameter, surface charge, and polydispersity are highly dependent on concentration, ionic strength, pH, and molecular parameters of the polymers that are used. In particular, the complexation between polyelectrolytes with significantly different molecular weights leads to the formation of water-insoluble aggregates. Several PEC characteristics are favorable for cellular uptake and colloidal stability, including hydrodynamic diameter less than 200 nm, surface charge of >30 mV or <−30 mV, spherical morphology, and polydispersity index (PDI) indicative of a homogeneous distribution. Maintenance of these properties is critical for a successful delivery vehicle. This review focuses on the development and potential applications of PECs as multi-functional, site-specific nanoparticulate drug/gene delivery and imaging devices.
引用
收藏
页码:2353 / 2369
页数:16
相关论文
共 783 条
  • [81] Pariat C.(2002) cytotoxicity of Stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells Pharm. Res. 19 1185-1193
  • [82] Cecchelli R.(2006)A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs J. Biol. Chem. 281 15757-15762
  • [83] Couet W.(1976)Characterization of nanoparticle uptake by endothelial cells Cell 9 663-674
  • [84] Labhasetwar V.(1996)Origin, originality, functions, subversions and molecular signalling of macropinocytosis Biochim. Biophys. Acta Mol. Basis Dis. 1317 5-14
  • [85] Bonadio J.(2001)A quantitative assessment of nonspecific pinocytosis by human endothelial cells surviving in vitro Int. J. Pharm. 221 143-152
  • [86] Goldstein S. A.(2001)Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport J. Biol. Chem. 276 32806-32813
  • [87] Levy J. R.(2004)Constitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M–CSF) Mol. Ther. 10 1011-1022
  • [88] Coester C.(2002)Analysis of a mutant strain of human fibroblasts with a defect in internalization of receptor-bound low-density lipoprotein J. Biol. Chem. 277 2437-2443
  • [89] Nayyar P.(2003)Increased macrophage uptake of irreversibly glycated albumin modified low density lipoproteins of normal and diabetic subjects is mediated by non-saturable mechanisms Trends Biochem. Sci. 28 145-151
  • [90] Samuel J.(1999)Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA−mPEG nanoparticles Biochem. J. 338 317-323